

Centromere antibodies are a type of antinuclear antibody (ANA) that targets specific proteins in the centromere region of chromosomes. These antibodies are most commonly found in patients with autoimmune connective tissue diseases, especially limited systemic sclerosis (CREST syndrome), which can cause skin thickening, Raynaud’s phenomenon, and involvement of internal organs. Detecting centromere antibodies aids clinicians in diagnosing these disorders early and differentiating them from other autoimmune or rheumatologic conditions.
The Centromere Antibody test is recommended for individuals showing signs and symptoms suggestive of systemic sclerosis or related autoimmune conditions, such as skin thickening, Raynaud’s phenomenon (discoloration of fingers and toes in response to cold or stress), fingertip ulcers, joint stiffness, or unexplained fatigue. It is particularly useful in confirming systemic sclerosis and differentiating it from other autoimmune diseases. The test may also be advised for patients already diagnosed with systemic sclerosis to monitor disease activity and assess the effectiveness of treatment. Additionally, it is considered for those with a family history of autoimmune connective tissue disorders, as they may be at a higher risk of developing these conditions.
Overnight fasting is preferred for this test, but it is not mandatory. However, it is preferred that you share your clinical history, current medications, and supplement use with your doctor before giving the sample, as these may influence the results.
Test result ranges are approximate and may differ slightly between labs depending on the methodology and laboratory guidelines. Do not self-medicate, and always consult a doctor to understand the test results correctly.
Please note: This is an outsourced test. The sample is collected by TATA 1MG and processed at a NABL accredited partnered lab.
The Centromere Antibody test measures the presence and level of antibodies that target centromere proteins in the blood. Centromeres are structures within chromosomes that play a key role in cell division. When the immune system mistakenly produces antibodies against these proteins, it can lead to autoimmune reactions affecting connective tissues, blood vessels, and internal organs.
High levels of centromere antibodies are strongly associated with limited systemic sclerosis (CREST syndrome), while low or absent levels are usually seen in healthy individuals or those with other autoimmune conditions. Detecting these antibodies helps clinicians confirm a diagnosis, assess disease severity, and monitor potential complications over time.
The Centromere Antibody test is done:
- If you have symptoms of autoimmune disease, such as skin thickening, Raynaud’s phenomenon (color changes in fingers/toes), fingertip ulcers, joint pain, or tiredness
- To help diagnose limited systemic sclerosis (CREST syndrome)
- To check if Raynaud’s phenomenon is linked to systemic sclerosis
- To tell apart systemic sclerosis from other autoimmune diseases
- To monitor disease activity and see how it is progressing
- To check if treatment for systemic sclerosis is working and to look for possible complications like pulmonary hypertension
- If you have a family history of autoimmune connective tissue diseases
- Clinical history is preferred.
- Overnight fasting is preferred but not mandatory. Follow the doctor's instructions regarding fasting requirements.






















